Skip survey header

Phase 2/3 Clinical Study to evaluate PTX-022 in PC

If you are interested in participating in the Phase 2/3 Clinical Trial, please fill out the information below:
Contact Information *This question is required.
What is your affected gene? *This question is required.
Have you been in a clinical trial in the past 60 days? *This question is required.
Are you willing to travel? *This question is required.
Are you willing to have home health visits? *This question is required.
(enter your initials in box)
Signature *This question is required.
Clear
Signature of
This question requires a valid date format of MM/DD/YYYY.
calendar